WallStSmart
PCRX

Pacira BioSciences, Inc.

NASDAQ: PCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$22.74
-1.77% today

Updated 2026-05-11

Market cap
$910.90M
P/E ratio
178.08
P/S ratio
1.24x
EPS (TTM)
$0.13
Dividend yield
52W range
$19 – $28
Volume
0.7M

Pacira BioSciences, Inc. (PCRX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-29.19M$-20.84M$-24.88M$-31.00M$-70.13M$-43.22M$25.47M$29.00M$33.45M$17.79M$48.87M$70.52M$77.03M$125.72M$145.27M$154.65M$189.39M$151.99M
Capital expenditures$5.84M$5.51M$6.77M$6.17M$18.26M$12.79M$21.89M$41.27M$24.71M$19.27M$14.51M$10.16M$37.80M$45.87M$30.08M$15.16M$10.64M$15.33M
Depreciation
Stock-based comp$242000.00$524000.00$23000.00$2.49M$4.78M$11.51M$24.82M$33.37M$31.25M$31.60M$31.73M$33.65M$39.92M$42.25M$48.09M$47.90M$51.17M$57.50M
Free cash flow$-35.03M$-26.35M$-31.65M$-37.17M$-88.39M$-56.01M$3.58M$-12.27M$8.74M$-1.48M$34.36M$60.36M$39.23M$79.85M$115.20M$139.49M$178.75M$136.66M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.32M$1.62M$2.67M$2.81M
Share repurchases
Debt repayment
Net change in cash$20.04M$-36.04M$2.39M$25.00M$19.46M$-21.04M$18.18M$78.40M$-54.30M$21.73M$485.62M